Found 81 results
Author [ Title(Asc)] Type Year
Filters: Author is William H. Bisson  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
A. Sehrawat, Gao, L., Wang, Y., Bankhead, A., McWeeney, S. K., King, C. J., Schwartzman, J., Urrutia, J., Bisson, W. H., Coleman, D. J., Joshi, S. K., Kim, D. - H., Sampson, D. A., Weinmann, S., Kallakury, B. V. S., Berry, D. L., Haque, R., Van Den Eeden, S. K., Sharma, S., Bearss, J., Beer, T. M., Thomas, G. V., Heiser, L. M., and Alumkal, J. J., LSD1 activates a lethal prostate cancer gene network independently of its demethylase function., Proc Natl Acad Sci U S A, 2018.
M. F. Miller, Goodson, W. H., Manjili, M. H., Kleinstreuer, N., Bisson, W. H., and Lowe, L., Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research Recommendations., Environ Health Perspect, 2017.
B. C. Goodale, La Du, J., Tilton, S. C., Sullivan, C. M., Bisson, W. H., Waters, K. M., and Tanguay, R. L., Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs., Toxicol Sci, vol. 147, no. 2, pp. 397-411, 2015.
B. C. Goodale, La Du, J. K., Tilton, F., Sullivan, C. M., Bisson, W. H., Waters, K. M., and Tanguay, R. L., Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs, Toxicological Sciences, vol. 147, no. 2, pp. 397 - 411, 2015.
B. C. Goodale, La Du, J. K., Tilton, S. C., Sullivan, C. M., Bisson, W. H., Waters, K. M., and Tanguay, R., Ligand-specific transcriptional mechanisms underlie aryl hydrocarbon receptor-mediated developmental toxicity of oxygenated PAHs, Toxicological Sciences, p. kfv139, 2015.
W. H. Bisson, Scapozza, L., Westera, G., Mu, L., and Schubiger, P. A., Ligand selectivity for the acetylcholine binding site of the rat $\alpha$4$\beta$2 and $\alpha$3$\beta$4 nicotinic subtypes investigated by molecular docking, Journal of medicinal chemistry, vol. 48, pp. 5123–5130, 2005.
I
C. Jiang, Xie, C., Lv, Y., Li, J., Krausz, K. W., Shi, J., Brocker, C. N., Desai, D., Amin, S. G., Bisson, W. H., Liu, Y., Gavrilova, O., Patterson, A. D., and Gonzalez, F. J., Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction, Nature Communications, vol. 6, p. 10166, 2015.
F. J. Gonzalez, Jiang, C., Bisson, W. H., and Patterson, A. D., Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity, Journal of hepatology, 2015.
J. Ochieng, Nangami, G. N., Ogunkua, O., Miousse, I. R., Koturbash, I., Odero-Marah, V., McCawley, L., Nangia-Makker, P., Ahmed, N., Luqmani, Y., and Bisson, W. H., The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis, Carcinogenesis, vol. 36, pp. S128–S159, 2015.
H. Sang Jang, Pearce, M. C., O'Donnell, E. F., Nguyen, B. Duc, Truong, L., Mueller, M. J., Bisson, W. H., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S., Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells., Biology (Basel), vol. 6, no. 4, 2017.
H. Jang, Pearce, M. C., O'Donnell, E. F., Nguyen, B., Truong, L., Mueller, M. J., Bisson, W. H., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S., Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells, Biology (Basel), vol. 6, no. 4, 2017.
K. J. Smith, Murray, I. A., Tanos, R., Tellew, J., Boitano, A. E., Bisson, W. H., Kolluri, S., Cooke, M. P., and Perdew, G. H., Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism, Journal of Pharmacology and Experimental Therapeutics, vol. 338, pp. 318–327, 2011.

Pages